Cargando…

Androgen receptor expression reduces stemness characteristics of prostate cancer cells (PC3) by repression of CD44 and SOX2

Studies have shown that a subgroup of tumor cells possess stemness characteristics having self‐renewal capacity and the ability to form new tumors. We sought to identify the plausible stemness factor that determines the “molecular signature” of prostate cancer (PCa) cells derived from different meta...

Descripción completa

Detalles Bibliográficos
Autores principales:	Srinivasan, Deepa, Senbanjo, Linda, Majumdar, Sunipa, Franklin, Renty B., Chellaiah, Meenakshi A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2018
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6411465/ https://www.ncbi.nlm.nih.gov/pubmed/30206982 http://dx.doi.org/10.1002/jcb.27573

Ejemplares similares

Characterization of CD44 intracellular domain interaction with RUNX2 in PC3 human prostate cancer cells
por: Senbanjo, Linda T., et al.
Publicado: (2019)

Identification of sequence-specific interactions of the CD44-intracellular domain with RUNX2 in the transcription of matrix metalloprotease-9 in human prostate cancer cells
por: Senbanjo, Linda T., et al.
Publicado: (2020)

Peptidomimetic inhibitor of L-plastin reduces osteoclastic bone resorption in aging female mice
por: Aljohani, Hanan, et al.
Publicado: (2021)

CD44: A Multifunctional Cell Surface Adhesion Receptor Is a Regulator of Progression and Metastasis of Cancer Cells
por: Senbanjo, Linda T., et al.
Publicado: (2017)

C-phycocyanin attenuates RANKL-induced osteoclastogenesis and bone resorption in vitro through inhibiting ROS levels, NFATc1 and NF-κB activation
por: AlQranei, Mohammed S., et al.
Publicado: (2020)

Peptidomimetic inhibitors of L-plastin reduce the resorptive activity of osteoclast but not the bone forming activity of osteoblasts in vitro
por: Chellaiah, Meenakshi A., et al.
Publicado: (2018)

Mechanisms of osteopontin and CD44 as metastatic principles in prostate cancer cells
por: Desai, Bhavik, et al.
Publicado: (2007)

Methylsulfonylmethane increases osteogenesis and regulates the mineralization of the matrix by transglutaminase 2 in SHED cells
por: Aljohani, Hanan, et al.
Publicado: (2019)

Regulation of Erk1/2 activation by osteopontin in PC3 human prostate cancer cells
por: Robertson, Brian W, et al.
Publicado: (2010)

Sox2 Is an Androgen Receptor-Repressed Gene That Promotes Castration-Resistant Prostate Cancer
por: Kregel, Steven, et al.
Publicado: (2013)

Engineering of L-Plastin Peptide-Loaded Biodegradable Nanoparticles for Sustained Delivery and Suppression of Osteoclast Function In Vitro
por: Majumdar, Sunipa, et al.
Publicado: (2019)

Osteopontin and MMP9: Associations with VEGF Expression/Secretion and Angiogenesis in PC3 Prostate Cancer Cells
por: Gupta, Aditi, et al.
Publicado: (2013)

Membrane Localization of Membrane Type 1 Matrix Metalloproteinase by CD44 Regulates the Activation of Pro-Matrix Metalloproteinase 9 in Osteoclasts
por: Chellaiah, Meenakshi A., et al.
Publicado: (2013)

Integrin αvβ3 and CD44 pathways in metastatic prostate cancer cells support osteoclastogenesis via a Runx2/Smad 5/receptor activator of NF-κB ligand signaling axis
por: Gupta, Aditi, et al.
Publicado: (2012)

In vitro BMP2 stimulation of osteoblast citrate production in concert with mineralized bone nodule formation
por: Costello, Leslie C., et al.
Publicado: (2015)

Lipopolysaccharide- TLR-4 Axis regulates Osteoclastogenesis independent of RANKL/RANK signaling
por: AlQranei, Mohammed S., et al.
Publicado: (2021)

L-Plastin deficiency produces increased trabecular bone due to attenuation of sealing ring formation and osteoclast dysfunction
por: Chellaiah, Meenakshi A., et al.
Publicado: (2020)

A Proposed Efficacious Treatment with Clioquinol (Zinc Ionophore) and Cabergoline (Prolactin Dopamine Agonist) for the Treatment of Terminal Androgen-independent Prostate Cancer. Why and How?
por: Costello, Leslie C., et al.
Publicado: (2019)

Methylsulfonylmethane Increases the Alveolar Bone Density of Mandibles in Aging Female Mice
por: Aljohani, Hanan, et al.
Publicado: (2021)

Aberrant DNA Methylation and Prostate Cancer
por: Majumdar, Sunipa, et al.
Publicado: (2011)

Evidence that Osteoblasts are Specialized Citrate-producing Cells that Provide the Citrate for Incorporation into the Structure of Bone
por: Franklin, Renty B., et al.
Publicado: (2014)

The status of citrate in the hydroxyapatite/collagen complex of bone; and Its role in bone formation
por: Costello, Leslie C., et al.
Publicado: (2014)

V-ATPase-dependent repression of androgen receptor in prostate cancer cells
por: Licon-Munoz, Yamhilette, et al.
Publicado: (2018)

Transcriptional repression by androgen receptor: roles in castration-resistant prostate cancer
por: Gritsina, Galina, et al.
Publicado: (2019)

The clinical relevance of the metabolism of prostate cancer; zinc and tumor suppression: connecting the dots
por: Costello, Leslie C, et al.
Publicado: (2006)

Effect of AQP9 Expression in Androgen-Independent Prostate Cancer Cell PC3
por: Chen, Qiwei, et al.
Publicado: (2016)

Interleukin‐4 induces a CD44(high)/CD49b(high) PC3 subpopulation with tumor‐initiating characteristics
por: Erb, Holger H.H., et al.
Publicado: (2018)

Androgen receptor‐mediated transcriptional repression targets cell plasticity in prostate cancer
por: Erdmann, Éva, et al.
Publicado: (2022)

Testosterone, prolactin, and oncogenic regulation of the prostate gland. A new concept: Testosterone-independent malignancy is the development of prolactin-dependent malignancy!
por: Costello, Leslie C., et al.
Publicado: (2018)

Identification of miR-34a as a potent inhibitor of prostate cancer progenitor cells and metastasis by directly repressing CD44
por: Liu, Can, et al.
Publicado: (2011)

Effect of SOX2 Repression on Corneal Endothelial Cells
por: Hwang, Jin Sun, et al.
Publicado: (2020)

MTA3 Represses Cancer Stemness by Targeting the SOX2OT/SOX2 Axis
por: Du, Liang, et al.
Publicado: (2019)

Registered report: the microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44
por: Li, Jia, et al.
Publicado: (2015)

Replication Study: The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44
por: Yan, Xuefei, et al.
Publicado: (2019)

Interplay Between SOX9, Wnt/β-Catenin and Androgen Receptor Signaling in Castration-Resistant Prostate Cancer
por: Khurana, Namrata, et al.
Publicado: (2019)

Orphan nuclear receptor TLX contributes to androgen insensitivity in castration-resistant prostate cancer via its repression of androgen receptor transcription
por: Jia, Lin, et al.
Publicado: (2018)

REST mediates androgen receptor actions on gene repression and predicts early recurrence of prostate cancer
por: Svensson, Charlotte, et al.
Publicado: (2014)

BMI1 regulates androgen receptor in prostate cancer independently of the polycomb repressive complex 1
por: Zhu, Sen, et al.
Publicado: (2018)

PC44. The Link Between Obesity and Migraine: Does This Exist?
por: Saffari, Tiam Mana, et al.
Publicado: (2023)

High level expression of STAG1/PMEPA1 in an androgen-independent prostate cancer PC3 subclone
por: Hirokawa, Yoshifumi S., et al.
Publicado: (2007)

Cannot write session to /tmp/vufind_sessions/sess_nccgb1bliu384c3ffd1dic91i2